A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors
Jiangsu Nutai Biologics Co., Ltd
Jiangsu Nutai Biologics Co., Ltd
CivaTech Oncology
Boehringer Ingelheim
Shanghai Juncell Therapeutics
Mundipharma Research Limited
Akeso
Pure Biologics S.A.
Disruptive Pharma
TransCode Therapeutics
Bexion Pharmaceuticals, Inc.
Presage Biosciences
Telix Pharmaceuticals (Innovations) Pty Limited
Instituto de Medicina Regenerativa
Shanghai Pharmaceuticals Holding Co., Ltd
Istari Oncology, Inc.
Ratio Therapeutics, Inc.
Nanexa AB
ARTBIO Inc.
Presage Biosciences
Bracco Diagnostics, Inc
SmartNuclide Biopharma
Five Eleven Pharma, Inc.
TuHURA Biosciences, Inc.
Presage Biosciences
Jazz Pharmaceuticals
Center for Biomedical Research, Inc.
Boston Scientific Corporation
Daiichi Sankyo
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Clarity Pharmaceuticals Ltd
Applied Biology, Inc.
InnoPharmax Inc.
Epigenomics, Inc
Siemens Molecular Imaging
Siemens Molecular Imaging
Siemens Molecular Imaging